# reload+after+2024-01-22 19:47:31.354737
address1§8030 El Rio Street
city§Houston
state§TX
zip§77054
country§United States
phone§346 355 4099
website§https://www.alaunos.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor engine. The company has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; and a patent license agreement, and research and development agreement with the National Cancer Institute. The company was formerly known as ZIOPHARM Oncology, Inc. and changed its name to Alaunos Therapeutics, Inc. in January 2022. Alaunos Therapeutics, Inc. was founded in 2003 and is headquartered in Houston, Texas.
fullTimeEmployees§34
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Kevin S. Boyle Sr.', 'age': 49, 'title': 'CEO & Director', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 888818, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Michael  Wong', 'age': 43, 'title': 'Vice President of Finance & Principal Accounting Officer', 'yearBorn': 1980, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§9
boardRisk§6
compensationRisk§9
shareHolderRightsRisk§3
overallRisk§6
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§-0.177
priceToSalesTrailing12Months§2101.4758
currency§USD
dateShortInterest§1702598400
forwardEps§-0.04
exchange§NCM
quoteType§EQUITY
shortName§Alaunos Therapeutics, Inc.
longName§Alaunos Therapeutics, Inc.
firstTradeDateEpochUtc§1124890200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§05ce1922-a43a-368b-a87c-0906e2ee068e
gmtOffSetMilliseconds§-18000000
targetHighPrice§2.0
targetLowPrice§1.5
targetMeanPrice§1.75
targetMedianPrice§1.75
recommendationMean§3.0
recommendationKey§hold
numberOfAnalystOpinions§2
quickRatio§2.554
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
